Article: Sale a shot in the arm for Alesco's balance sheet.

Byline: Michael Smith

Apr 27, 2009 (The Australian Financial Review - ABIX via COMTEX) -- The sale of one division has improved the prospects of Alesco Corporation. The industrial brands group sold its scientific and medical business, Biolab, to US company Thermo Fisher Scientific for $A175 million. This will reduce its debt so that ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!